Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

4 terminated/withdrawn out of 28 trials

Success Rate

82.6%

-3.9% vs industry average

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

0%

0 of 19 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
23(88.5%)
Phase 1
1(3.8%)
Phase 3
1(3.8%)
Phase 2
1(3.8%)
26Total
N/A(23)
Phase 1(1)
Phase 3(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (28)

Showing 20 of 28 trials
NCT07193927Phase 2Recruiting

Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial

Role: lead

NCT07454525Not ApplicableNot Yet Recruiting

Examine Impact of Topical Application of Active Versus Placebo on the Skin Microbiome in Sensitive Skin.

Role: lead

NCT05271747Not ApplicableCompleted

Prospective Study to Determine the Factors Influencing Infant Colic

Role: lead

NCT06192966Not ApplicableTerminated

Effect of Probiotics on Recurrent Urinary Tract Infections

Role: lead

NCT07343544Not ApplicableNot Yet Recruiting

Clinical Trial to Assess the Efficacy and Safety of a Cosmetic Product in Individuals Showing Signs of Cutaneous Aging.

Role: lead

NCT06604234Not ApplicableCompleted

Impact of a Probiotic Combination on Quality of Life and Symptoms in Peri- and Postmenopausal Women

Role: lead

NCT05524649Not ApplicableRecruiting

Effect of Probiotics on Infant's Fecal Microbiota Composition

Role: lead

NCT06670807Not ApplicableNot Yet Recruiting

Effect of a Probiotic Formula in Mild Cognitive Impairement

Role: collaborator

NCT06193096Not ApplicableCompleted

Impact of a Probiotic-based Formula on Digestive Symptoms and Mood in Ultra Marathon Runners

Role: lead

NCT02529462Phase 3Completed

Trial to Evaluate Efficacy of Pharmacogenetic Information Obtained With NEUROPHARMAGEN in Treatment of MDD Patients

Role: lead

NCT05279534Not ApplicableTerminated

Efficacy and Safety of L. Plantarum and P. Acidilactici in Children With Upper Respiratory Tract Infections

Role: lead

NCT05688397Not ApplicableCompleted

Evaluation of the Vaginal Colonization of Two New Lactobacillus Strains After Oral Administration in Healthy Volunteers

Role: lead

NCT04316806Not ApplicableTerminated

Effect of a Probiotic Formula on Reducing SIBO in IBS Patients

Role: lead

NCT05157425Not ApplicableCompleted

Effect of a Multi-strain Probiotic Formulation on Immune Response to Influenza Vaccination

Role: lead

NCT05378230Not ApplicableCompleted

Probiotic Intervention, Bile Acids and Lipid Metabolism Metabolic Profile in Healthy Overweight Subjects.

Role: collaborator

NCT04823676Not ApplicableCompleted

Efficacy and Safety of a Probiotic Composition as Adjunct in MAFL Management

Role: lead

NCT04944628Completed

Observational Prospective Study With Probiotic Supplementation on Infants With FGDI

Role: lead

NCT04923204Completed

Utility of the Pharmacogenetic Information Provided by NEUROPHARMAGEN in the Treatment of Bipolar Depressionwith Bipolar Depression

Role: lead

NCT04517422Not ApplicableCompleted

Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19

Role: lead

NCT04677335Not ApplicableCompleted

Combination of AB-LIFE Probiotic Plus Monacolin K to Reduce Blood Cholesterol

Role: lead